BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29947713)

  • 1. Melanin particles isolated from the fungus Fonsecaea pedrosoi activates the human complement system.
    Pinto L; Granja LFZ; Almeida MA; Alviano DS; Silva MHD; Ejzemberg R; Rozental S; Alviano CS
    Mem Inst Oswaldo Cruz; 2018 Jun; 113(8):e180120. PubMed ID: 29947713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the human complement system by pigmented and hypopigmented mycelia of the fungus Fonsecaea pedrosoi.
    Pinto L; Granja LF; Alviano DS; da Silva MH; Alviano CS; Ejzemberg R
    Mycoses; 2011 Sep; 54(5):e474-80. PubMed ID: 21554418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanin from Fonsecaea pedrosoi induces production of human antifungal antibodies and enhances the antimicrobial efficacy of phagocytes.
    Alviano DS; Franzen AJ; Travassos LR; Holandino C; Rozental S; Ejzemberg R; Alviano CS; Rodrigues ML
    Infect Immun; 2004 Jan; 72(1):229-37. PubMed ID: 14688100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the alternative complement pathway by fungal melanins.
    Rosas AL; MacGill RS; Nosanchuk JD; Kozel TR; Casadevall A
    Clin Diagn Lab Immunol; 2002 Jan; 9(1):144-8. PubMed ID: 11777844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanin in Fonsecaea pedrosoi: a trap for oxidative radicals.
    Cunha MM; Franzen AJ; Seabra SH; Herbst MH; Vugman NV; Borba LP; de Souza W; Rozental S
    BMC Microbiol; 2010 Mar; 10():80. PubMed ID: 20233438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural characterization of melanosomes of the human pathogenic fungus Fonsecaea pedrosoi.
    Franzen AJ; Cunha MM; Miranda K; Hentschel J; Plattner H; da Silva MB; Salgado CG; de Souza W; Rozental S
    J Struct Biol; 2008 Apr; 162(1):75-84. PubMed ID: 18096404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of melanin synthesis pathway by tricyclazole increases susceptibility of Fonsecaea pedrosoi against mouse macrophages.
    Cunha MM; Franzen AJ; Alviano DS; Zanardi E; Alviano CS; De Souza W; Rozental S
    Microsc Res Tech; 2005 Dec; 68(6):377-84. PubMed ID: 16358282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of nitric oxide production by macrophages in chromoblastomycosis: a role for Fonsecaea pedrosoi melanin.
    Bocca AL; Brito PP; Figueiredo F; Tosta CE
    Mycopathologia; 2006 Apr; 161(4):195-203. PubMed ID: 16552481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of pksA attenuates the melanogenesis, growth and sporulation ability and causes increased sensitivity to stress response and antifungal drugs in the human pathogenic fungus Fonsecaea monophora.
    Xiao X; Li Y; Lan Y; Zhang J; He Y; Cai W; Chen Z; Xi L; Zhang J
    Microbiol Res; 2021 Mar; 244():126668. PubMed ID: 33359842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the alternative complement pathway by Fonsecaea pedrosoi.
    Torinuki W; Okohchi K; Takematsu H; Tagami H
    J Invest Dermatol; 1984 Oct; 83(4):308-10. PubMed ID: 6481182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of melanin content of Fonsecaea pedrosoi using Fourier transform infrared spectroscopy (FTIR) and chemometrics.
    Koehler A; de Moraes PC; Heidrich D; Scroferneker ML; Ferrão MF; Corbellini VA
    Spectrochim Acta A Mol Biomol Spectrosc; 2024 Apr; 310():123945. PubMed ID: 38295590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoprecipitation techniques and Elisa in the detection of anti-Fonsecaea pedrosoi antibodies in chromoblastomycosis.
    Vidal MS; de Castro LG; Cavalecate SC; Lacaz Cda S
    Rev Inst Med Trop Sao Paulo; 2003; 45(6):315-8. PubMed ID: 14762630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biology and pathogenesis of Fonsecaea pedrosoi, the major etiologic agent of chromoblastomycosis.
    Santos AL; Palmeira VF; Rozental S; Kneipp LF; Nimrichter L; Alviano DS; Rodrigues ML; Alviano CS
    FEMS Microbiol Rev; 2007 Sep; 31(5):570-91. PubMed ID: 17645522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphometric and densitometric study of the biogenesis of electron-dense granules in Fonsecaea pedrosoi.
    Franzen AJ; de Souza W; Farina M; Alviano CS; Rozental S
    FEMS Microbiol Lett; 1999 Apr; 173(2):395-402. PubMed ID: 15586434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.
    Falk RJ; Dalmasso AP; Kim Y; Tsai CH; Scheinman JI; Gewurz H; Michael AF
    J Clin Invest; 1983 Aug; 72(2):560-73. PubMed ID: 6348093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular typing using polymorphisms of the polyketide synthase gene (PKS1) of strains in Japan morphologically identified as Fonsecaea pedrosoi.
    Ushigami T; Anzawa K; Mochizuki T
    J Dermatol; 2017 Jan; 44(1):36-42. PubMed ID: 27162115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure, cellular distribution, antigenicity, and biological functions of Fonsecaea pedrosoi ceramide monohexosides.
    Nimrichter L; Cerqueira MD; Leitão EA; Miranda K; Nakayasu ES; Almeida SR; Almeida IC; Alviano CS; Barreto-Bergter E; Rodrigues ML
    Infect Immun; 2005 Dec; 73(12):7860-8. PubMed ID: 16299276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation of Fonsecaea pedrosoi into sclerotic cells links to the refractoriness of experimental chromoblastomycosis in BALB/c mice via a mechanism involving a chitin-induced impairment of IFN-γ production.
    Dong B; Tong Z; Li R; Chen SC; Liu W; Liu W; Chen Y; Zhang X; Duan Y; Li D; Chen L
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006237. PubMed ID: 29481557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A monoclonal antibody to glucosylceramide inhibits the growth of Fonsecaea pedrosoi and enhances the antifungal action of mouse macrophages.
    Nimrichter L; Barreto-Bergter E; Mendonça-Filho RR; Kneipp LF; Mazzi MT; Salve P; Farias SE; Wait R; Alviano CS; Rodrigues ML
    Microbes Infect; 2004 Jun; 6(7):657-65. PubMed ID: 15158773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of extracellular enzymes from chromoblastomycosis agents reveals the potential association of phospholipase with the severity of the lesions.
    Montoya AM; Montesino CA; Carrión-Álvarez D; González GM; Rojas OC
    Microb Pathog; 2020 Oct; 147():104367. PubMed ID: 32649963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.